UCB · 14 hours ago
E&BI Monitoring Program Lead US
Atlanta, GA
Full-time
Hybrid
Mid, Senior Level
$124K/yr - $163K/yr
5+ years expUCB is a global biopharmaceutical company focusing on neurology and immunology. They are seeking an E&BI Insights Monitoring Program Lead to drive the strategic direction and execution of monitoring and analytics within the compliance function, overseeing vendor management and risk management.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Develop and refine monitoring strategies and annual plans in line with business needs
Collaborate with regional leads to align monitoring with local regulations
Oversee and manage external vendors for E&BI monitoring activities
Report monitoring activities, findings, and trends to senior leadership
Manage High Impact Findings (HIF) and drive continuous improvement
Use analytics tools to provide actionable insights for risk management
Qualification
Required
Bachelor's degree or higher in a relevant field
5+ years' experience in US healthcare compliance or risk management
Preferred
At least 2 years in a leadership or managerial role
Experience leading teams or managing vendors in a multinational environment
Proven expertise in global healthcare regulatory standards and compliance analytics
Relevant professional certifications (e.g., CCEP, CFE, CPA, CHC, CCEP-I)
Experience with advanced analytics tools (e.g., Qlik, Power BI)
Strong project management and communication skills
Experience presenting to senior leadership and external stakeholders
Ability to adapt monitoring plans to diverse regulatory environments
Company
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease.
5001-10000 employees
H1B Sponsorship
UCB has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (7)
2023 (3)
2022 (4)
2021 (4)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$201.75MKey Investors
Financière de Tubize SAPaul Capital
2022-05-23Post Ipo Equity· $100.96M
2015-05-13Post Ipo Equity· $0.79M
2009-12-22Post Ipo Equity· $100M
Leadership Team
Jean-Christophe Tellier
CEO
Stefanos Grammatikos
Senior Vice President - Head of CMC Development Sciences
Recent News
Company data provided by crunchbase